Pitt Shield

The emerging field of non-invasive brain stimulation in Alzheimer's disease.

Authors: Koch G, Altomare D, Benussi A, Bréchet L, Casula EP, Dodich A, Pievani M, Santarnecchi E, Frisoni GB

Treating cognitive impairment is a holy grail of modern clinical neuroscience. In the past few years, non-invasive brain stimulation is increasingly emerging as a therapeutic approach to ameliorate performance in patients with cognitive impairment and as an augmentation approach in persons whose cognitive performance is within normal limits. In patients with Alzheimer's disease, better understanding of brain connectivity and function has allowed for the development of different non-invasive brain stimulation protocols. Recent studies have shown that transcranial stimulation methods enhancing brain plasticity with several modalities have beneficial effects on cognitive functions. Amelioration has been shown in preclinical studies on behaviour of transgenic mouse models for Alzheimer's pathology and in clinical studies with variable severity of cognitive impairment. While the field is still grappling with issues related to the standardization of target population, frequency, intensity, treatment duration and stimulated region, positive outcomes have been reported on cognitive functions and on markers of brain pathology. Here we review the most encouraging protocols based on repetitive transcranial magnetic stimulation, transcranial direct current stimulation, transcranial alternating current stimulation, visual-auditory stimulation, photobiomodulation and transcranial focused ultrasound, which have demonstrated efficacy to enhance cognitive functions or slow cognitive decline in patients with Alzheimer's disease. Beneficial non-invasive brain stimulation effects on cognitive functions are associated with the modulation of specific brain networks. The most promising results have been obtained targeting key hubs of higher-level cognitive networks, such as the frontal-parietal network and the default mode network. The personalization of stimulation parameters according to individual brain features sheds new light on optimizing non-invasive brain stimulation protocols for future applications.

Introduction

Purpose Other
Study Objective To review and summarize current evidence on non-invasive brain stimulation techniques for treating or slowing cognitive impairment across the spectrum from subjective cognitive decline and mild cognitive impairment to Alzheimer's disease dementia.
Animal model / Human subject Mus musculus (transgenic mouse models for Alzheimer’s pathology); strain not specified; age not specified; sex not specified
Disease model Alzheimer's disease

Outcomes and Safety

Summary of Outcomes Non-invasive brain stimulation techniques (rTMS, tDCS, tACS, visual–auditory stimulation, photobiomodulation, and transcranial focused ultrasound) have been reported to improve cognitive function and slow cognitive decline in Alzheimer's disease by modulating key networks (frontal–parietal and default mode); no specific focused ultrasound parameters were reported as tested or successful in this review.
Safety-related matter The provided text does not mention any safety concerns, adverse effects, or tolerability issues related to the non-invasive brain stimulation techniques discussed.

Brain Region

Visualization unavailable

Ultrasound Parameters

Focal Characteristics Focal depth: None; Focal length: None; Aperture size: None
Treatment frequency Multiple sessions

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search